Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acer Therapeutics
Acer Therapeutics
(ACER)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Olpruva
Phenylbutyric acid
2022-12-22
Ornithine carbamoyltransferase deficiency disease
,
Carbamoyl-phosphate synthase i deficiency disease
,
Citrullinemia
,
Amyotrophic lateral sclerosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Phenylbutyric acid
alzheimer disease
,
central nervous system diseases
,
nervous system diseases
,
spinal cord diseases
,
tdp-43 proteinopathies
,
neuromuscular diseases
,
syndrome
,
wolfram syndrome
,
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
neurodegenerative diseases
,
parkinsonian disorders
,
progressive supranuclear palsy
,
paralysis
Celiprolol
postoperative complications
,
cardiac arrhythmias
,
ehlers-danlos syndrome
,
type iv ehlers-danlos syndrome
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
syndrome
,
williams syndrome
Bevifimod
lupus nephritis
,
nephritis
,
psoriasis
,
chronic disease
Zotiraciclib
chronic obstructive pulmonary disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use